These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 31905878)
1. Identifying Ortholog Selective Fragment Molecules for Bacterial Glutaredoxins by NMR and Affinity Enhancement by Modification with an Acrylamide Warhead. Khattri RB; Morris DL; Bilinovich SM; Manandhar E; Napper KR; Sweet JW; Modarelli DA; Leeper TC Molecules; 2019 Dec; 25(1):. PubMed ID: 31905878 [TBL] [Abstract][Full Text] [Related]
2. An NMR-Guided Screening Method for Selective Fragment Docking and Synthesis of a Warhead Inhibitor. Khattri RB; Morris DL; Davis CM; Bilinovich SM; Caras AJ; Panzner MJ; Debord MA; Leeper TC Molecules; 2016 Jul; 21(7):. PubMed ID: 27438815 [TBL] [Abstract][Full Text] [Related]
3. Fragment library screening identifies hits that bind to the non-catalytic surface of Pseudomonas aeruginosa DsbA1. Mohanty B; Rimmer K; McMahon RM; Headey SJ; Vazirani M; Shouldice SR; Coinçon M; Tay S; Morton CJ; Simpson JS; Martin JL; Scanlon MJ PLoS One; 2017; 12(3):e0173436. PubMed ID: 28346540 [TBL] [Abstract][Full Text] [Related]
4. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy. Maurer T Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602 [TBL] [Abstract][Full Text] [Related]
5. Development of potent inhibitors of pyocyanin production in Pseudomonas aeruginosa. Miller LC; O'Loughlin CT; Zhang Z; Siryaporn A; Silpe JE; Bassler BL; Semmelhack MF J Med Chem; 2015 Feb; 58(3):1298-306. PubMed ID: 25597392 [TBL] [Abstract][Full Text] [Related]
6. Multiparameter Kinetic Analysis for Covalent Fragment Optimization by Using Quantitative Irreversible Tethering (qIT). Craven GB; Affron DP; Kösel T; Wong TLM; Jukes ZH; Liu CT; Morgan RML; Armstrong A; Mann DJ Chembiochem; 2020 Dec; 21(23):3417-3422. PubMed ID: 32659037 [TBL] [Abstract][Full Text] [Related]
8. Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors. Wyss DF; Wang YS; Eaton HL; Strickland C; Voigt JH; Zhu Z; Stamford AW Top Curr Chem; 2012; 317():83-114. PubMed ID: 21647837 [TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria. Hernandez V; Crépin T; Palencia A; Cusack S; Akama T; Baker SJ; Bu W; Feng L; Freund YR; Liu L; Meewan M; Mohan M; Mao W; Rock FL; Sexton H; Sheoran A; Zhang Y; Zhang YK; Zhou Y; Nieman JA; Anugula MR; Keramane el M; Savariraj K; Reddy DS; Sharma R; Subedi R; Singh R; O'Leary A; Simon NL; De Marsh PL; Mushtaq S; Warner M; Livermore DM; Alley MR; Plattner JJ Antimicrob Agents Chemother; 2013 Mar; 57(3):1394-403. PubMed ID: 23295920 [TBL] [Abstract][Full Text] [Related]
10. Binding Mode Characterization and Early in Vivo Evaluation of Fragment-Like Thiols as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa. Kany AM; Sikandar A; Haupenthal J; Yahiaoui S; Maurer CK; Proschak E; Köhnke J; Hartmann RW ACS Infect Dis; 2018 Jun; 4(6):988-997. PubMed ID: 29485268 [TBL] [Abstract][Full Text] [Related]
11. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor. Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943 [TBL] [Abstract][Full Text] [Related]
12. Identification and validation of a novel anti-virulent that binds to pyoverdine and inhibits its function. Wang X; Kleerekoper Q; Revtovich AV; Kang D; Kirienko NV Virulence; 2020 Dec; 11(1):1293-1309. PubMed ID: 32962519 [No Abstract] [Full Text] [Related]
13. Small-molecule inhibitors of nisin resistance protein NSR from the human pathogen Streptococcus agalactiae. Porta N; Zaschke-Kriesche J; Frieg B; Gopalswamy M; Zivkovic A; Etzkorn M; Stark H; Smits SHJ; Gohlke H Bioorg Med Chem; 2019 Oct; 27(20):115079. PubMed ID: 31500943 [TBL] [Abstract][Full Text] [Related]
14. Discovery of PqsE Thioesterase Inhibitors for Valastyan JS; Tota MR; Taylor IR; Stergioula V; Hone GAB; Smith CD; Henke BR; Carson KG; Bassler BL ACS Chem Biol; 2020 Feb; 15(2):446-456. PubMed ID: 31880429 [No Abstract] [Full Text] [Related]
19. A Practical Perspective on the Roles of Solution NMR Spectroscopy in Drug Discovery. Li Q; Kang C Molecules; 2020 Jun; 25(13):. PubMed ID: 32605297 [TBL] [Abstract][Full Text] [Related]
20. Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N Zhong W; Koay A; Ngo A; Li Y; Nah Q; Wong YH; Chionh YH; Ng HQ; Koh-Stenta X; Poulsen A; Foo K; McBee M; Choong ML; El Sahili A; Kang C; Matter A; Lescar J; Hill J; Dedon P ACS Infect Dis; 2019 Mar; 5(3):326-335. PubMed ID: 30682246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]